Sponsor-Backed Lending: What the Sponsor Promises

In owner-managed lending, the owner's whole position stands behind the business: often a personal guarantee, the family home as security, and a lifetime's stake that the owner will defend. A sponsor's position is different in each respect. Its exposure is limited to what its fund invested. The fund has a fixed life and investors expecting returns. And it owns a portfolio, so one company's failure is a loss to be weighed against the cost of saving it.

The sponsor brings things an owner often does not: professional management of the capital structure, board discipline, monthly reporting, and access to equity for acquisitions. It also brings negotiating power. A sponsor that borrows across many portfolio companies is a repeat customer, and lenders compete for its deals on leverage and terms as much as on price. That competition is why sponsor documents are often looser than an owner-managed borrower's, with equity cure rights, wider baskets and, in larger deals, covenant-lite terms.

At purchase, the sponsor's money usually goes in as ordinary shares and shareholder loans. Both rank behind the lenders: the shares by nature, the loans because the lenders require them subordinated. The shareholder loans let the sponsor take returns as interest or repayment rather than dividends, but in a failure they are worth no more than the shares. The structure gives the lender a cushion that is real on day one. What it does not give is any obligation to top it up.

One supervisor treats ownership itself as a risk signal. The European Central Bank's 2017 guidance for the significant banks it supervises asks them to count a loan to a borrower more than half owned by a financial sponsor as a leveraged transaction, whatever its leverage, subject to listed exclusions such as small exposures and investment-grade borrowers. That guidance has no direct force in New Zealand, Australia or the UK, but it shows how the ownership, not only the ratio, is read.

A provider of electrical testing and inspection services, constructed for this page like every figure in it, is bought by a fund for US$100m, ten times EBITDA of US$10m. The lenders provide US$45m; the fund puts in US$55m, of which US$40m is a subordinated shareholder loan and US$15m shares. The net leverage covenant is 5.00 times, and the agreement lets the sponsor cure a breach with new equity applied to debt. In year three two large contracts are lost. Every level is the example's.

In the first case the cure is cheap insurance for a stake still worth US$27m, and a sponsor has good reason to pay it. In the second, buyers will pay only five times a business that has just lost two large contracts; the value has dropped below the debt, and new money would mostly benefit the lenders. A sponsor may still support the business, to protect its reputation with lenders or because the fund has capital set aside, but the lender cannot assume it. The same sponsor, with the same record, behaves differently because its stake is worth something different.

DEFINED IN ONE PARAGRAPH → · EQUITY CURE → · LOAN TO ENTERPRISE VALUE →

A management buy-out without a fund is financed on the managers' own money, the seller's patience and the bank's loan, and the managers may guarantee part of it. The lender reads people who have put their own wealth at risk and cannot walk away. Many buyouts are both: a fund provides most of the equity and the managers buy a smaller stake. There the lender reads two owners with different incentives, the fund looking to the exit and the managers to the business.

A sponsor credit paper carries a section an owner-managed one does not: the sponsor itself. It records the fund's size and age, how much capital it has left for support, and how the sponsor behaved when earlier portfolio companies struggled, whether it injected equity, negotiated, or handed over the keys. A sponsor with a record of support earns better terms. It has not promised to repeat them.

The documents then decide how early the lender gets to the table. Maintenance covenants, tested quarterly, bring the sponsor to a conversation while its equity still has value and support is rational. Covenant-lite terms, a generous cure right or a long clean-up period can delay that conversation until the equity is gone and the sponsor's incentive with it. In all three markets banks and private credit funds compete for these loans, and the share each wins differs by market and deal size.

BANK LOAN VS PRIVATE CREDIT → · DIVIDEND RECAPITALISATION → · UNITRANCHE →